In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…
HealthPatch, Body Guardian, other wearable cardiac monitors could be considered for wider use among patients with rheumatoid arthritis
Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA
Research shows women with RA at risk of preterm birth
Rheumatologist Richard Brasington, MD, says patient John Reigstad’s active participation in treatment decisions shows how much improving quality of life matters
The ACR shares highlights of in-development guidelines for RA combination strategies, live vaccines and biologics
Combination therapy includes abatacept for patient with erosive, chronic RA, underlying osteoarthritis and degenerative disk disease
Chronic inflammation, cancer and autoimmunity are inextricably linked